I Maragno

500 total citations
46 papers, 395 citations indexed

About

I Maragno is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, I Maragno has authored 46 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 12 papers in Physiology. Recurrent topics in I Maragno's work include Cardiac electrophysiology and arrhythmias (12 papers), Nitric Oxide and Endothelin Effects (8 papers) and Ion channel regulation and function (6 papers). I Maragno is often cited by papers focused on Cardiac electrophysiology and arrhythmias (12 papers), Nitric Oxide and Endothelin Effects (8 papers) and Ion channel regulation and function (6 papers). I Maragno collaborates with scholars based in Italy, Austria and Brazil. I Maragno's co-authors include P. Dorigo, R.M. Gaion, Giovanni Santostasi, G. Fassina, Daniela Fraccarollo, Luisa Mosti, João Gualberto de Cerqueira Luz, Michelle C. Martin, F. Benetollo and G. Bombieri and has published in prestigious journals such as Journal of Medicinal Chemistry, European Heart Journal and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

I Maragno

45 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Maragno Italy 13 133 122 115 81 28 46 395
Michael E. Beil Switzerland 12 144 1.1× 125 1.0× 95 0.8× 32 0.4× 40 1.4× 28 447
Ernst Mutschler Germany 9 79 0.6× 226 1.9× 44 0.4× 47 0.6× 28 1.0× 22 485
Mary Quade United States 9 143 1.1× 240 2.0× 109 0.9× 52 0.6× 14 0.5× 10 422
V.C. Swamy United States 12 136 1.0× 375 3.1× 172 1.5× 50 0.6× 8 0.3× 26 594
Roy Jordan United Kingdom 9 109 0.8× 171 1.4× 106 0.9× 61 0.8× 5 0.2× 12 382
K. Stoepel Germany 12 231 1.7× 194 1.6× 91 0.8× 67 0.8× 5 0.2× 38 534
Akira Tomiyama Japan 12 105 0.8× 188 1.5× 86 0.7× 48 0.6× 4 0.1× 33 364
E. Karge Germany 12 128 1.0× 81 0.7× 181 1.6× 21 0.3× 13 0.5× 43 491
Sakae Murata United States 12 187 1.4× 145 1.2× 141 1.2× 80 1.0× 3 0.1× 45 433
Klaus-Otto Minck Germany 9 86 0.6× 168 1.4× 74 0.6× 53 0.7× 5 0.2× 17 373

Countries citing papers authored by I Maragno

Since Specialization
Citations

This map shows the geographic impact of I Maragno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Maragno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Maragno more than expected).

Fields of papers citing papers by I Maragno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Maragno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Maragno. The network helps show where I Maragno may publish in the future.

Co-authorship network of co-authors of I Maragno

This figure shows the co-authorship network connecting the top 25 collaborators of I Maragno. A scholar is included among the top collaborators of I Maragno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Maragno. I Maragno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cappellin, Enrico, Raffaele Delli Gatti, Paolo Spinella, et al.. (2001). Plasma atrial natriuretic peptide (ANP) fragments proANP (1–30) and proANP (31–67) measurements in chronic heart failure: a useful index for heart trasplantation?. Clinica Chimica Acta. 310(1). 49–52. 15 indexed citations
2.
Dorigo, P., Maura Floreani, Giovanni Santostasi, et al.. (2000). Pharmacological Characterization of a New Ca2+Sensitizer. Journal of Pharmacology and Experimental Therapeutics. 295(3). 1004–1014. 2 indexed citations
3.
Santostasi, Giovanni, Daniela Fraccarollo, P. Dorigo, et al.. (1998). Early reduction in plasma norepinephrine during beta-blocking therapy with metoprolol in chronic heart failure. Journal of Cardiac Failure. 4(3). 177–184. 5 indexed citations
4.
Dorigo, P., Daniela Fraccarollo, Giovanni Santostasi, & I Maragno. (1997). Impairment of endothelium‐dependent but not of endothelium‐independent dilatation in guinea‐pig aorta rings incubated in the presence of elevated glucose. British Journal of Pharmacology. 121(5). 972–976. 30 indexed citations
5.
Dorigo, P., Daniela Fraccarollo, R.M. Gaion, et al.. (1997). New inotropic agents: Milrinone analogs. General Pharmacology The Vascular System. 28(5). 781–788. 13 indexed citations
6.
Dorigo, P., Giovanni Santostasi, Daniela Fraccarollo, & I Maragno. (1994). Inotropic agents in development. Expert Opinion on Investigational Drugs. 3(5). 457–468. 4 indexed citations
7.
Dorigo, P., R.M. Gaion, Daniela Fraccarollo, et al.. (1993). A pharmacological, crystallographic, and quantum chemical study of new inotropic agents. Journal of Medicinal Chemistry. 36(17). 2475–2484. 36 indexed citations
8.
Dorigo, P., et al.. (1992). Vasodilatory activity of etozoline in rat and guinea-pig isolated aorta: study of the mechanism of action.. PubMed. 315. 63–78. 2 indexed citations
9.
Dorigo, P., et al.. (1991). An analysis of the mechanism of the inotropic action of some milrinone analogues in guinea‐pig isolated atria. British Journal of Pharmacology. 104(4). 867–872. 9 indexed citations
10.
Dorigo, P., et al.. (1990). Different action of milrinone analogs in guinea-pig atria. General Pharmacology The Vascular System. 21(4). 511–515. 1 indexed citations
11.
Gaion, R.M., et al.. (1990). Etozoline and vascular spasm. Pharmacological Research. 22. 123–124. 3 indexed citations
12.
Dorigo, P., et al.. (1990). Comparison between the cardiac effects induced by muzolimine and furosemide in guinea-pig atria. Cardiovascular Drugs and Therapy. 4(6). 1477–1485. 7 indexed citations
13.
Dorigo, P., et al.. (1989). Amrinone potentiates catecholamine-induced lipolysis in fat cells. Biochemical Pharmacology. 38(5). 855–858. 5 indexed citations
14.
Dorigo, P., R.M. Gaion, & I Maragno. (1988). Negative and positive influences exerted by purine compounds on isolated guinea‐pig atria. Journal of Autonomic Pharmacology. 8(3). 191–196. 9 indexed citations
15.
Dorigo, P., et al.. (1988). The response of isolated guinea‐pig aorta to amrinone. Journal of Autonomic Pharmacology. 8(1). 19–28. 1 indexed citations
16.
Maragno, I, et al.. (1988). Low- and medium-dose diltiazem in chronic atrial fibrillation: Comparison with digoxin and correlation with drug plasma levels. American Heart Journal. 116(2). 385–392. 23 indexed citations
17.
Santostasi, Giovanni, et al.. (1987). Effects of Amiodarone on Oral and Intravenous Digoxin Kinetics in Healthy Subjects. Journal of Cardiovascular Pharmacology. 9(4). 385–390. 19 indexed citations
18.
Scognamiglio, R, et al.. (1986). Variability of positive inotropic response to acute amrinone administration in chronic cardiac failure. European Heart Journal. 7(7). 621–627. 2 indexed citations
19.
Maragno, I, P. Dorigo, & G. Fassina. (1971). Effect of antimycin a on hormone-stimulated lipolysis in vitro. Biochemical Pharmacology. 20(9). 2149–2154. 7 indexed citations
20.
Fassina, G., I Maragno, & P. Dorigo. (1967). Metabolic inhibitors and catecholamine-stimulated lipolysis. Biochemical Pharmacology. 16(8). 1439–1446. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026